1. Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads.
- Author
-
Kumar A, Novoselov V, Celeste AJ, Wolfman NM, ten Dijke P, and Kuehn MR
- Subjects
- Activins, Animals, Bone Morphogenetic Proteins physiology, DNA-Binding Proteins genetics, Embryonal Carcinoma Stem Cells, Epidermal Growth Factor physiology, GPI-Linked Proteins, Gene Expression Regulation, Neoplastic drug effects, Genes, Reporter, Growth Substances metabolism, Humans, Membrane Proteins metabolism, Mice, Mutation, Neoplasm Proteins genetics, Neoplasm Proteins metabolism, Neoplastic Stem Cells metabolism, Nodal Protein, Phosphorylation drug effects, Recombinant Proteins pharmacology, Smad2 Protein, Smad3 Protein, Trans-Activators genetics, Transfection, Tumor Cells, Cultured, DNA-Binding Proteins metabolism, Homeodomain Proteins, Inhibins metabolism, Intercellular Signaling Peptides and Proteins, Membrane Glycoproteins, Receptors, Transforming Growth Factor beta metabolism, Signal Transduction drug effects, Trans-Activators metabolism, Transcription Factors, Transforming Growth Factor beta pharmacology, Xenopus Proteins
- Abstract
Nodal, a member of the transforming growth factor beta (TGF-beta) superfamily, is implicated in many events critical to the early vertebrate embryo, including mesoderm formation, anterior patterning, and left-right axis specification. Here we define the intracellular signaling pathway induced by recombinant nodal protein treatment of P19 embryonal carcinoma cells. Nodal signaling activates pAR3-Lux, a luciferase reporter previously shown to respond specifically to activin and TGF-beta. However, nodal is unable to induce pTlx2-Lux, a reporter specifically responsive to bone morphogenetic proteins. We also demonstrate that nodal induces p(CAGA)(12), a reporter previously shown to be specifically activated by Smad3. Expression of a dominant negative Smad2 significantly reduces the level of luciferase reporter activity induced by nodal treatment. Finally, we show that nodal signaling rapidly leads to the phosphorylation of Smad2. These results provide the first direct biochemical evidence that nodal signaling is mediated by both activin-TGF-beta pathway Smads, Smad2 and Smad3. We also show here that the extracellular cripto protein is required for nodal signaling, making it distinct from activin or TGF-beta signaling.
- Published
- 2001
- Full Text
- View/download PDF